SCOTTSDALE, Ariz.—Confluent Medical Technologies Inc. recently reported that it has expanded its supply agreement with Allegheny Technologies (ATI) for the manufacture and supply of ELI Nitinol, a specialized metal alloy used primarily to produce high-performance minimally invasive medical devices and components.
Under the revised agreement, Confluent will provide funding to increase the furnace capacity at ATI Specialty Alloys and Components to produce ELI Nitinol at ATI’s Albany, Oregon site by 33 percent. Confluent has full access to production volumes through 2026, the company said in a release.
“Expanding our strategic partnership with ATI is an important investment for Confluent,” said Dean Schauer, president and CEO of Confluent, in the release. “This investment significantly increases the available supply of ELI Nitinol material, which is in high demand for the most critical medical device applications. Securing additional melt capacity for this unique, high-purity, high-fatigue-resistant material allows us to meet increasing demand for current customers, while also expanding availability for new offerings of medical device products and components.”